Key Factors Influencing the Endoscopy Equipment Market Growth
According to a new report by MarketsandMarkets™. - Endoscopy Equipment Market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029.
The growth in this market is primarily driven by factors such as increasing prevalence of gastrointestinal diseases, rising demand for minimally invasive surgeries, technological advancements leading to enhanced imaging and procedural capabilities, expanding healthcare infrastructure, and growing awareness about early disease diagnosis and treatment.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689
In the forecast period, the endoscopes segment dominated the global endoscopy equipment market. This significant share can be credited to the increasing favouritism of minimally invasive procedures by both patients and healthcare professionals, along with the elevated uptake of such equipment by end users. Moreover, continuous advancements in endoscopy technologies contribute to the segment's substantial presence in the market.
Based on application, the obstetrics/gynecology endoscopy segment of the endoscopy equipment market accounted the third largest market share in the forecast period. This growth subjected to the rising incidence of gynaecological conditions like endometriosis, uterine fibroids. Technological improvements in visualization systems and endoscopes, accessories tools like grasping tools are driving the growth of the gynecology endoscopy segment as well.
Ambulatory surgery centers/clinics secure the second-largest market share in the endoscopy equipment market. This largest share comes from the increasing trend towards outpatient procedures due to their convenience and cost-effectiveness. Additionally, the rising demand for minimally invasive surgeries in these settings drives the adoption of advanced endoscopy equipment. As ambulatory surgery centers continue to grow in popularity, the demand for endoscopy equipment in these facilities is expected to witness steady growth in the foreseeable future.
Europe to possess the second largest market share in the endoscopy equipment market in the forecast period due to its rising investments towards medical technology, high adoption rates of advanced medical technologies, and increasing prevalence of gastrointestinal diseases. These factors drive demand for endoscopy equipment, positioning Europe as one of the leading market regions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=689
Endoscopy Equipment Market Dynamics:
Drivers:
Growing focus of hospitals to invest in technologically advanced endoscopy instruments and expand endoscopy units
Restraints:
High overhead costs of endoscopy procedures with limited reimbursement in developing countries
Opportunities:
Booming healthcare sector in developing economies
Challenge:
Shortage of trained physicians and endoscopicts
Key Market Players of Endoscopy Equipment Industry:
Prominent players in the endoscopy equipment market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Boston Scientific Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, plc (Ireland), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), Nipro Corporation (Japan), Smith & Nephew plc (UK), Intuitive Surgical, Inc. (US)
A breakdown of the primary participants (supply side) for the endoscopy equipment market referred to for this report is provided below:
By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
By Designation: C-level–45%, Director Level–25%, and Others–30%
By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America-10%, and Middle East & Africa_ 7%
Recent Developments of Endoscopy Equipment Industry:
In November 2023, Olympus Corporation launched the EVIS X1, an advanced endoscopy system in the existing product portfolio of the company.
In September 2023, Stryker launched, 1788, a minimally invasive surgical camera, offering more vibrant image with balanced lighting.
In January 2022, The Johnson & Johnson Medical Devices Companies (JJMDC) collaborated with Microsoft Corporation Inc, (US) to enable and expand JJMDC’s secure and compliant digital surgery ecosystem.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=689
Endoscopy Equipment Market - Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the endoscopic equipment market and its segments. This research will assist stakeholders understand the competitive landscape, obtain insights to better position their firms, and develop appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
Analysis of key Drivers: Drivers (rising requirement for endoscopy to diagnose and treat target diseases, increasing investments, funds, and grants by governments and other organizations, growing focus of hospitals to expand endoscopic units, ongoing advancements in endoscopic technologies, rising incidence of inflammatory bowel disease and colorectal cancer, increasing preference for minimally invasive surgeries, higher adoption of single-use endoscopy instruments, rising focus of medical specialists to shift from manual to automated endoscopy reprocessing), Restrains (unfavourable healthcare reforms in US, high overhead costs of endoscopy procedures with limited reimbursement in emerging economies, high risk of getting viral infections during endoscopic procedures), Opportunities (rapidly developing healthcare sector in emerging economies), Challenges (increasing number of product recalls, lack of proper sterilization and reprocessing, shortage of trained physicians and endoscopists) influencing the growth of the endoscopy equipment market.
Market Penetration: Comprehensive information on the product portfolios of the leading companies in the endoscopic equipment market. The report breaks down the market by product type, end user, and region.
Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the endoscopic equipment market.
Market Development: Comprehensive data on attractive rising markets broken down by product category, application, end user, and region
Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the endoscopic equipment market.
Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main endoscopic equipment manufacturers.
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/endoscopy-devices-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/endoscopy.asp
Companion Diagnostics: Empowering Targeted Treatment Strategies
According to a new report by MarketsandMarkets™ - Companion Diagnostics Market in terms of revenue was estimated to be worth $7.5 billion in 2024 and is poised to reach $13.6 billion by 2029, growing at a CAGR of 12.6% from 2024 to 2029.
The global companion diagnostics market is poised for significant growth in the near future, driven by the increasing incidence of cancers worldwide. This rise in cancer cases is fueling the demand for more accurate and personalized treatment options. Companion diagnostics play a crucial role in this scenario by helping to select appropriate targeted therapies for patients based on their genetic makeup and likely response. This personalized approach is expected to improve treatment outcomes while reducing adverse reactions to unsuited medicines. Additionally, the approvals of many targeted oncology drugs, along with complementary companion diagnostics, by regulatory agencies are expected to further propel the market growth. Emerging economies like China, Japan, and India are presenting attractive opportunities for companies operating in this market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681
Based on product & service, the companion diagnostics market is segmented into assays, kits & reagents, instruments/systems and software & services. The dominance of the assays, kits & reagents segment in 2023 can be attributed primarily to the broad range of available products and the rapidly increasing utilization of assays and kits across various therapeutic areas.
Based on technology, the companion diagnostics market is categorized into polymerase chain reaction (PCR), in situ hybridization (ISH), next-generation sequencing (NGS), immunohistochemistry (IHC), and other technologies. In 2023, the PCR segment held the largest portion of the companion diagnostics market. PCR has become essential in companion diagnostics, especially in the interpretive practice by pharmaceutical companies related to oncology drugs, due to its reliability, sensitivity, and ability to obtain quantitative results. Its extensive range of applications and established market presence give it a significant position in the field.
Based on indication, the companion diagnostics market is segmented into cancer, cardiovascular diseases (CVDs), neurological diseases, infectious diseases, and other indications (inflammatory and inherited diseases, among others). In 2023, the cancer segment held the largest share of the companion diagnostics market. This can be attributed to factors such as the expanding role of companion diagnostics in personalized medicine treatments for cancer, as well as the growing importance of biomarkers in cancer diagnosis.
Based on sample type, the companion diagnostics market is segmented into liquid, blood, and other sample types. In 2023, the tissue sample segment accounted for the largest share of the companion diagnostics market. Tissue samples are often preferred in companion diagnostics for their ability to provide a direct analysis of the tumor, offering a comprehensive view of genetic mutations and biomarkers for more accurate and personalized treatment decisions.
Based on end user, the companion diagnostics market is segmented into pharmaceutical & biotechnology companies, reference laboratories, CROs, and other end users (including physician & hospital laboratories and academic medical centers). The pharmaceutical & biotechnology companies segment held the largest share of the companion diagnostics market in 2023. This is primarily driven by factors such as the rising utilization of companion diagnostics in drug development and the growing significance of companion diagnostic biomarkers.
The global companion diagnostics market is divided into six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. In 2023, North America held the largest portion of the companion diagnostics market. The growth of the North American companion diagnostics market can be credited to several factors, including the significant presence of leading companion diagnostics vendors and national clinical laboratories. Additionally, the easy access to technologically advanced devices and instruments, along with the highly developed healthcare systems in the US and Canada, contributed to the market's expansion in this region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155571681
Companion Diagnostics Market Dynamics:
Drivers:
Increasing significance of personalized medicine
Restraints:
High capital investment and low cost-benefit ratio
Opportunities:
Increasing importance of companion diagnostics in drug development
Challenge:
The shortage of adequately trained professionals
Key Market Players of Companion Diagnostics Industry:
The major players in this market are F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), Thermo Fisher Scientific Inc. (US), Abbott (US), Almac Group (UK), Danaher (US), Illumina, Inc. (US), bioMérieux (France), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), ARUP Laboratories (UK), Abnova Corporation (Taiwan), Guardant Health (US), ICON Plc (Ireland), BioGenex (US), Invivoscribe, Inc. (US), ArcherDX, Inc. (Integrated DNA Technologies, Inc.) (US), NG Biotech (France), Q² Solutions (US), Amoy Diagnostics Co., Ltd. (China), Uniogen (Abacus Diagnostica) (Finland), Asuragen, Inc. (Bio-Techne) (US), NG Biotech (France), Meso Scale Diagnostics, LLC. (US), and Creative Biolabs (US).
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 -35%
By Designation: C-level - 30%, D-level - 20%, and Others - 50%
By Region: North America - 42%, Europe - 31%, Asia Pacific - 20%, and Rest of the World -7%
Recent Developments of Companion Diagnostics Industry:
In August 2023, Agilent Technologies, Inc. (US) received European IVDR Certification for Companion Diagnostic Assay.
In August 2023, QIAGEN (Netherlands). received FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT (avapritinib) in gastrointestinal stromal tumors.
In March 2023, F. Hoffmann-La Roche Ltd (Switzerland) received FDA approval of label expansion for VENTANA PD- L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo.
In September 2022, Thermo Fisher Scientific Inc. (US) announced FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers.
In January 2021, F. Hoffmann-La Roche Ltd (Switzerland) launched two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer.
Companion Diagnostics Market - Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall companion diagnostics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the companion diagnostics market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the companion diagnostics market.
Market Development: Comprehensive information about lucrative markets – the report analyses the companion diagnostics market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the companion diagnostics market.
Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), Thermo Fisher Scientific Inc. (US) and Abbott (US).
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/companion-diagnostics-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/companion-diagnostics.asp
Understanding Consumer Preferences: Key Drivers in the Optometry Equipment Market
According to a new report by MarketsandMarkets™ - Optometry Equipment Marketin terms of revenue was estimated to be worth $4.5 billion in 2024 and is poised to reach $6.1 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029.
The principal drivers propelling the expansion of this market are the growing prevalence of eye illnesses, advancements in ophthalmic device technology, expanding government initiatives aimed at preventing visual impairment, growing healthcare expenses, and rising disposable incomes. Companies in the market for optometry equipment are finding that developing nations like China, Japan, and India provide attractive opportunities.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14475790
According to product type, the worldwide optometry equipment market is divided into three segments: goods for general examinations, cornea and cataract examinations, and products for glaucoma and retinal examinations. In2023, the optometry equipment market was dominated by the sector that produced examination goods for glaucoma and retina. The significant portion of the market is due to a variety of factors, including the expansion of clinics, the increasing incidence of glaucoma and retinal disorders, the easier availability to modern ophthalmic diagnostic technologies, and technological advancements in optometry equipment.
The market for optometry equipment is divided into segments based on applications, including age-related macular degeneration, cataract surgery, glaucoma, and general exams. As of 2023, the worldwide optometry equipment market was dominated by the general examination segment. The primary factors influencing this segment's size include the aging population, the rise in the prevalence of eye diseases, and the number of cases of diabetes and hypertension.
By end user, the optometry equipment market is divided into eye clinics, hospitals, and other consumers. The sector that held the biggest share of the global optometry equipment market in 2023 was clinics. This sector makes up a sizeable share of the market because of the vast number of patients treated in clinics and the increasing number of private clinical practices founded by ophthalmologists in emerging countries.
There are five main regions that make up the global market for optometry equipment: North America, Europe, Asia Pacific, and Rest of the World (which includes Latin America, the Middle East & Africa, and GCC countries). In terms of market share, North America led the optometry equipment market in 2023. Some of the contributing factors are the rising prevalence of ocular diseases, the rapidly aging population, the accessibility of state-of-the-art optometry equipment, and the growing utilization of ophthalmology procedures and therapies in this field.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=14475790
Optometry Equipment Market Dynamics:
Drivers:
1. Increasing incidence of eye disorders
a. Cataracts
b. Glaucoma
2. Technological advancements in ophthalmic devices
3. Rising government initiatives to control visual impairment
4. Increasing healthcare expenditure
Restraints:
1. High cost of optometry equipment
2. Growing adoption of refurbished optometry equipment
Opportunities:
1. Growth opportunities in emerging markets
Challenge:
1. Growth opportunities in emerging markets
Key Market Players of Optometry Equipment Industry:
The major players leading in optometry equipment market are Carl Zeiss Meditec AG (Germany), EssilorLuxottica (France), Alcon (Switzerland), Topcon Corporation (Japan), Bausch Health Companies Inc. (Canada), NIDEK Co. Ltd. (Japan), Canon Inc. (Japan), Johnson and Johnson (US), HEINE Optotechnik (Germany), Revenio Group PLC (Finland), Haag-Streit Group (Switzerland) and Heidelberg Engineering (Germany).
Breakdown of supply-side primary interviews, by company type, designation, and region:
· By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
· By Designation: C-level (27%), Director-level (18%), and Others (55%)
· By Region: North America (51%), Europe (21%), Asia- Pacific (18%), Latin America (6%), and Middle East & Africa(4%)
Recent Developments of Optometry Equipment Industry:
· In August 2023, Carl Zeiss launched the ZEISS trifocal technology on a glistening-free hydrophobic C-loop platform and a fully preloaded injector for safe and reliable implantation.
· In March 2022, Topcon Corporation launched SOLOS, an automatic lens analyzer that enables advanced, accurate, and efficient lens analysis at the touch of a button.
· In September 2023, Bauch + Lomb acquired XIIDRA to grow in the prescription dry eyes segment.
· In January 2023Bausch + Lomb acquired AcuFocus to expand its cataract surgical portfolio.
Optometry Equipment Market - Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall optometry equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
· Analysis of key drivers (High prevalence of eye diseases, growing geriatric population), restraints (High Cost and use of refurbished equipments), opportunities (Rising healthcare expenditure, Increasing Demand from Emerging Economies), and challenges (low awareness, limited insurance coverage) influencing the growth of the optometry equipment market.
· Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the optometry equipment market
· Market Development: Comprehensive information about lucrative markets – the report analyses the optometry equipment market across varied regions.
· Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the optometry equipment market
· Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Carl Zeiss Meditec AG (Germany), EssilorLuxottica (France), Alcon (Switzerland), Topcon Corporation (Japan) and Bausch Health Companies Inc. (Canada), among others in optometry equipment market.
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/optometry-eye-exam-equipment-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/optometry-eye-exam-equipment.asp
Challenges and Opportunities in Home Healthcare
Home Healthcare Market in terms of revenue was estimated to be worth $250.0 billion in 2023 and is poised to reach $383.0 billion by 2028, growing at a CAGR of 8.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. The primary drivers propelling the growth of this market are the aging population, rising healthcare expenditures, and the increased need for home care due to technological advancements in home healthcare.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696
The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. In 2022, the home healthcare market will be dominated by therapeutic items, primarily because chronic illnesses like diabetes, cancer, and kidney failure are becoming more common.
The home healthcare market on the basis of service is divided into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. Skilled nursing services have the biggest market share for home healthcare in 2022. The industry is expanding due to factors including the aging population.
On the basis of the indication, the home healthcare market has been segregated into cancer, respiratory diseases, movement disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. By 2022, the home healthcare market's greatest share belonged to the other indications category. The growing older population and kidney problems are the main factors propelling this market's expansion.
The global home healthcare market is segmented into four major regions—North America, Europe, the Asia Pacific, and Rest of the World. North America held the biggest market share for home healthcare in 2022. Due to its high disposable income and growing senior population, North America accounts for a sizable portion of the global industry. On the other hand, throughout the course of the forecast period, the Asia Pacific market is anticipated to develop at the highest CAGR. Rising disposable income and government initiatives to promote home healthcare are the main factors driving growth in the Asia Pacific home healthcare industry.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=696
Home Healthcare Market Dynamics:
Drivers:
1. Rapid growth in elderly population and rising incidence of chronic diseases
2. Rising R&D investments
3. Need for cost-effective healthcare delivery due to rising costs
4. Increased preference for personalized care
Restraint:
1. Changing reimbursement policies
2. Limited insurance coverage
3. Patient safety concerns
Opportunities:
1. Rising focus on telehealth
2. Untapped developing regions
3. Growing demand for home-use therapeutic devices
4. Growing demand for home sleep apnea tests
5. Rising preference for home hemodialysis treatment
Challenge:
1. Shortage of home care workers
2. Lack of supporting infrastructure
Key Market Players of Home Healthcare Industry:
The major players operating in home healthcare market are Fresenius SE & Co. KGaA (Germany), Abbott (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), ResMed, Inc. (US), Linde, Plc (Ireland), F.Hoffmann-La Roche, Ltd. (Switzerland), A&D Company, Limited (Japan), Bayada Home Health Care (US), Invacare Corporation (US), Amedisys (US), LHC Group, Inc. (US), Omron Corporation (Japan), Drive Devilbiss Healthcare (UK), Hamilton Medical (Switzerland), Sunrise Medical (Germany), Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Pflegedienst Gmbh (Germany), Renafan Gmbh (Germany), ADMR (France), Apex Medical Corp. (Taiwan), Contec Medical Systems Co., Ltd. (China), Löwenstein Medical Technology Gmbh + Co., KG. (Germany), B. Braun Melsungen Ag (Germany), Baxter International, Inc. (US), Allied Healthcare Products, Inc. (US), Medline Industries, Inc. (US), and Advin Health Care (India).
Breakdown of supply-side primary interviews, by company type, designation, and region:
· By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
· By Designation: C-level (27%), Director-level (18%), and Others (55%)
· By Region: North America (51%), Europe (21%), Asia- Pacific (18%), Latin America (6%), and Middle East & Africa (4%)
Home Healthcare Market - Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall home healthcare market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
· Analysis of key drivers (High prevalence of chronic diseases, growing geriatric population), restraints (Alternative Technologies), opportunities (Rising healthcare expenditure, Increasing Demand from Emerging Economies), and challenges (stringent regulations, limited insurance coverage) influencing the growth of the home healthcare market.
· Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the home healthcare market
· Market Development: Comprehensive information about lucrative markets – the report analyses the home healthcare market across varied regions.
· Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the home healthcare market
· Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US), among others in home healthcare market.
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/home-healthcare-equipment-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/home-healthcare.asp
Advancements in Cartilage Repair Techniques: Current Landscape and Future Directions
Cartilage Repair Market / Cartilage Regeneration market in terms of revenue was estimated to be worth $1.3 Billion in 2023 and is poised to reach $2.8 Billion by 2028, growing at a CAGR of 17.2% from 2023 to 2028according to a latest report published by MarketsandMarkets™. Growth in the Cartilage Repair/Cartilage Regeneration market is mainly driven by the Increasing incidence of osteoarthritis, increasing research funding and investments and the Rising number of sports and accident-related orthopaedic injuries expected to grow the market demand Cartilage Repair/Cartilage Regeneration market during the forecast period.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272
Based on the treatment modality, the cartilage repair/cartilage regeneration market is divided into two categories which are cell-based including chondrocyte transplantation, growth factors, and stem cells and non-cell-based like tissue scaffolds and cell-free composites. In 2022, the cell-based segment had the largest share in the treatment modality segment which is mainly due to advancements in stem cell- therapies used for cartilage repair.
Based on the Application site, the cartilage repair/cartilage regeneration market is categorized into knees, hips, ankles & feet, and other application sites like nose and shoulder. In 2022, The knee segment holds the largest share of the cartilage repair/cartilage regeneration market. The factors responsible for the growth of the segment are the increasing number of knee arthroscopy procedures and the rising incidence of knee osteoarthritis cases globally.
Based on the Application, the global cartilage repair/cartilage regeneration market is broadly segmented into hyaline cartilage and fibrocartilage. The hyaline cartilage segment accounted for the largest share of the cartilage repair and regeneration market in 2022. Hyaline cartilage is expected to grow highest in the upcoming years due to the increasing number of cartilage repair procedures performed worldwide is the major factor driving the growth of this application segment. Technological advancements, product developments and launches, and growing partnerships between key market players and hospitals are also supporting market growth.
Based on the region segmentation, the cartilage repair/cartilage regeneration market is divided into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the largest share and expects to dominate the cartilage repair/cartilage regeneration market. Growth in the North American market is mainly driven by the rising growth opportunities in emerging economies and growing number of contracts and agreements between market players.
Cartilage Repair Market / Cartilage Regeneration market major players covered in the report, such as:
· Smith+Nephew (UK)
· DePuy Synthes (Johnson & Johnson) (US)
· Zimmer Biomet Holdings, Inc. (US)
· Stryker Corporation (US)
· Vericel Corporation (US)
· B. Braun Melsungen AG (US)
· Anika Therapeutics (US)
· CONMED Corporation (US)
· MEDIPOST (South Korea)
· RTI Surgical (US)
· Arthrex, Inc. (US)
· Regrow Biosciences (India)
· Geistlich Pharma AG (Switzerland)
· AlloSource (US)
· Orthocell Ltd, (Australia)
· Matricel GmbH (Germany)
· CartiHeal, Inc. (Israel)
· Regentis Biomaterials (Israel)
· Theracell Advanced Biotechnology (Greece)
· LifeNet Health (US)
· and Among Others
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=37493272
This research report categorizes the cartilage repair/cartilage regeneration market into the following segments and subsegments:
Regional Split
· North America
· Europe
· Asia Pacific
· Rest of the World
Treatment Modality Split
· Cell-based
· Chondrocyte Transplantation
· Stem Cells
· Growth Factors
· Non-cell-based
· Tissue Scaffolds
· Cell-free Composites
Application Split
· Knee
· Hip
· Ankle and Foot
· Other Application Sites
Application Site Split
· Hyaline Cartilage
· Fibrocartilage
Key Market Stakeholders:
· Senior Management
· End User
· Finance/Procurement Department
· R&D Department
Report Objectives:
· To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
· To define, describe, segment, and forecast the cartilage repair/cartilage regeneration market by Product, Application, Medical specialty and Region
· To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
· To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall cartilage repair/cartilage regeneration market
· To forecast the size of the cartilage repair/cartilage regeneration market in four main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, and Rest of the world
· To profile key players in the cartilage repair/cartilage regeneration market and comprehensively analyze their core competencies and market shares
· To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the cartilage repair/cartilage regeneration market.
· To benchmark players within the cartilage repair/cartilage regeneration market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cartilage-repair-regeneration-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/cartilage-repair-regeneration.asp
Strategies for Success in the Glycated Albumin Assay Market: Key Insights and Recommendations
Glycated Albumin Assay Market in terms of revenue was estimated to be worth $0.2 billion in 2023 and is poised to reach $0.3 billion by 2028, growing at a CAGR of 8.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. Government assistance is stimulating the market. Players in the glycated albumin assay market have significant potential in developing nations like India and Japan. Additionally, the aging population in developed and developing nations would favorably impact the market for glycated albumin assay. The prevalence of age-related illnesses like diabetes and pancreatic disorders is anticipated to rise dramatically as the senior population is forecast to grow quickly. Numerous test prescriptions to assess the levels of creatinine, albumin, glucose, ketones, and bilirubin are caused by diagnosing and treating such disorders, which is driving the market's expansion. Browse through 100 market data tables and 44 figures spread across 180 pages and the in-depth TOC of the glycated albumin assay market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=265553363
Based on application, the glycated albumin assay market is segmented into prediabetes, type 1 diabetes, and type 2 diabetes. The type 2 diabetes segment accounted for the largest share of the glycated albumin assay market, mainly due to increased focus on type 2 diabetes care and increased funding for diagnostic research.
The significant market share of this sector is mostly due to an increased emphasis on early disease diagnosis. Additionally, hospitals and diabetes care facilities are committed to providing patients with diabetes-specialized care. Their focus on comprehensive diabetes care makes them primary locations for conducting glycated albumin assays, which are important diagnostic tests for monitoring glycemic control.
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are the five main geographic segments of the worldwide glycated albumin assay market. In 2022, the glycated albumin assay market's largest regional market was North America. The government's support for regional research and increased funding for the creation of preventive care diagnostics can be used to explain North America's significant market dominance.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265553363
Glycated Albumin Assay Market Dynamics:
Drivers:
Rising prevalence of diabetes
Restraints:
Unfavorable reimbursement scenario
Opportunities:
Rising investments in healthcare and life sciences research
Challenges:
Changing regulatory landscape
Key Market Players:
The major players operating in this market are Asahi Kasei Corporation (Japan), Beijing Strong Biotechnologies, Inc. (China), Diazyme Laboratories, Inc. (US), DxGen Corp. (South Korea), Weldon Biotech (India), Hzymes Biotech (China).
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/glycated-albumin-assay-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/glycated-albumin-assay.asp
Future Perspectives: Emerging Technologies in the Medical Display Market
Medical Display Market in terms of revenue was estimated to be worth $ 2.3 billion in 2023 and is poised to reach $2.9 billion by 2028, growing at a CAGR of 5.2% from 2023 to 2028 according to a new report by MarketsandMarkets™.
The global Medical Display market is like rising technological advancements, increasing demand for diagnostic imaging, rising awareness and adoption of minimally invasive procedures and surge in telemedicine and remote diagnostics. However, market saturation in developed countries and increasing adoption of refurbished medical displays will be challenges in the growth of this market during the forecast period.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74058413
In this report, the Medical Display Market is segmented based on technology, panel size, resolution, display color, application and region.
The Medical Display Market is categorized into five segments, including technology, panel size, resolution, display color, application. Among these categories, the color segment in display color is projected to experience the highest growth rate from 2023 to 2028. Enhanced visualization, technological advancements, increasing complexity of medical imaging, improved patient care and safety, integration with picture archiving and communication systems (PACS), and advantages of color displays over grayscale displays such as enhanced contrast and differentiation, improved depth perception, enhanced communication and collaboration, multi-modality application are responsible for the large adoption of color display.
The Medical Display Market is categorized into different technology, including LED-Backlit LCD Displays, CCFL-Backlit LCD Displays, OLED Displays. Among these, the OLED displays segment held the fastest-growing market for medical display market in 2022. This significant market share can be attributed to factors such as fast response time and high refresh rates of OLED displays enable real-time visualization of moving structures, making them valuable for procedures that require precise guidance and monitoring, such as minimally invasive surgeries and endoscopy.
The Medical Display Market is segmented into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, Europe emerged as the second dominant market for Medical Display worldwide. The increasing demand for Medical Display and the availability of advanced technologies are expected to be major driving factors for market growth in Europe. The region's substantial market share can be attributed to its well-developed healthcare infrastructure and the continuous investment in research and development of medical devices.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=74058413
Medical Display Market Dynamics:
Drivers:
Growing Adoption of Hybrid Operating Rooms
Short Replacement Cycles of Medical Displays
Increasing Preference for Minimally Invasive Treatments
Rising Number of Diagnostic Imaging Centers
Restraints:
Market Saturation in Developed Countries
Increasing Adoption of Refurbished Medical Displays
Opportunities:
Development of Healthcare Infrastructure in Emerging Markets
Technological Advancements
Challenges:
Adoption of Consumer-Grade Displays
Fluctuating Average Selling Prices of Display Panels
Key Market Players:
The prominent players in the global Medical Display Market are Barco NV (Belgium), Eizo (Japan), Sony Electronics Inc. (Japan), Lg Electronics (South Korea), Novanta (US), FSN Medical Technologies (South Korea), Advantech (Taiwan), Quest International (US), Steris (UK), Jusha Medical (China), Siemens Healthineers Ag (Germany), Double Black Imaging (US), HP Development Co. Ltd (US), Stryker (US), and Coje Display (South Korea)
Recent Developments:
In April 2023, LG electronics launched 32HQ713D-B, which has latest high-resolution 8MP diagnostic medical monitor. It combines 1000 nits of brightness with LG’s proprietary IPS Black panel to deliver an enhanced 2,000:1 contrast ratio with deep blacks, while greatly simplifying color calibration through an automatic integrated sensor and software.
In February 2023, Eizo launched a 21.3-inch 2-megapixel (1200 x 1600 pixels) color monitor for displaying patient charts and reviewing diagnostic imaging in hospital and clinic environments.
In November 2022, Barco launched two displays. Io Gray 5.8 MP for the breast imaging and MDSC-8532 and MDSC-8527 4K UHD for surgical display.
In July 2022, Eizo launched launched four new monitors ranging from 32 to 55 inches with 4K UHD resolution (3840 x 2160 pixels) for use in endoscopy, microsurgery, and other high-precision procedures in the operating room (OR).
Medical Display market - Report Highlights:
Refinements in the segments of the medical display market
The current edition of the report consists of an updated market overview. Additional points in the market overview have been added, keeping in mind the impact of Recession impact on the overall medical display market. The new additions in this chapter include supply chain analysis, ecosystem analysis, regulatory analysis, value chain analysis, Porter’s five forces analysis, Company evaluation quadrants for start-ups/ SMEs and product portfolio analysis.
Coverage of new market players in the medical display market
Updated financial information/product portfolio of players
The new edition of the report provides updated financial information until 2022 for each listed company in a graphical representation as a single diagram (instead of multiple tables). This will easily help analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating country/region, business segment focus in terms of the highest revenue-generating segment, and R&D investments.
Updated market developments of profiled players recent developments are important to understand market trends and the growth strategies adopted by players. The current edition of this report provides updated developments of profiled players from January 2019 to August 2022, indicating a continuation from the previous version. Product/services launches, approvals, and upgrades, expansions, acquisitions, agreements, partnerships, and collaborations were the principal growth strategies adopted by market players in this period.
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/medical-display-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/medical-display.asp
Strategies for Market Penetration in Multiplex Assays Sector
Multiplex Assays Market in terms of revenue was estimated to be worth $3.5 billion in 2022 and is poised to reach $5.3 billion by 2027, growing at a CAGR of 8.8% from 2022 to 2027 according to a new report by MarketsandMarkets™.
Growth in this market is mainly driven by factors such as the emerging applications of multiplex assay in companion diagnostics and the growing need for automated and efficient systems in laboratories.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314
Report Coverage
Details
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Product & service, type, technology, application, end user, and region
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the World
Report Highlights
Updated financial information / product portfolio of players
The multiplex assays market is segmented into protein, nucleic acid, and cell-based multiplex assays according to type. The protein multiplex assays segment accounted for the largest share in the global multiplex assays market in 2022. As compared to traditional assays, protein multiplex assays prove to be faster and more efficient for protein profiling. Protein assays are highly efficient, require minimal sample volumes, and help reduce turnaround times; however, the equipment is expensive and requires skilled labor. This is expected to hamper the growth of the protein assays market.
Based on applications, the multiplex assays market is segmented into research & development and clinical diagnostics. The clinical diagnostics segment is further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, metabolism & endocrinology disorders, and other diseases. In 2022, the infectious diseases segment accounted for the largest share of the multiplex assays market for clinical diagnostics. Conventional analytical techniques that are used for the detection and identification of pathogens, such as ELISA and cell culture assays, take 2–3 days to produce results. Some multiplex assays, on the other hand, can provide results in a day or less; their rapidity is the key factor supporting their adoption in infectious disease diagnostics.
The global multiplex assays market has been segmented into five major regions—North America, Europe, the Asia Pacific, and the Rest of the World. In 2022, North America accounted for the largest share of the multiplex assays market. The large share of this region can be attributed to the highly advanced healthcare system in the US and Canada. Over the years, healthcare spending in North America has increased at a significant rate. National health spending is projected to grow at an average annual rate of 5.4% during 2019–2028 and reach USD 6.2 trillion by 2028 (Source: Centers for Medicare & Medicaid Services). The growing healthcare expenditure is also one of the major drivers for the biotechnology sector.
Multiplex Assays Market Dynamics:
Drivers:
Increasing prevalence of chronic respiratory diseases
Growing demand for emergency and intensive care
Growing incidence of pre-term births globally
Government support for improving emergency care infrastructure
Restraints:
Lack of reimbursement policies across developing countries
Opportunities:
Growing demand for single-use Multiplex Assays
Increased growth potential in emerging countries
Challenges:
Harmful effects of Multiplex Assays on neonatal patients
Dearth of skilled professionals for airway management procedures
Increasing pricing pressure on key market players
Key Market Players:
The major players operating in this market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), DiaSorin S.p.A. (Italy), QIAGEN N.V. (Netherlands), Abcam plc (UK), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Quanterix (US), Bio-Techne (US), MESO SCALE DIAGNOSTICS, LLC (US), Randox Laboratories Ltd. (UK), Olink (Sweden), Seegene Inc. (South Korea), Siemens Healthcare AG (Germany), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), Promega Corporation (US), Enzo Biochem Inc. (US), Cayman Chemical (US), Boster Biological Technology (US), Antigenix America, Inc. (US), Quansys Biosciences Inc. (US), and RayBiotech Life, Inc. (US).
Recent Developments:
In September 2021, Bio-Rad Laboratories launched its Bio-Plex Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens. The panels are for research use only (RUO).
In September, DiaSorin S.p.A. received the CE mark approval for its Simplexa COVID-19 & Flu A/B Direct kit, a multiplex test for the in vitro qualitative detection and differentiation of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus, and influenza B virus from the same patient sample in one reaction well. The assay is designed for use on the LIAISON MDX and is run directly from nasopharyngeal swabs (NPS) without the need for offboard extraction.
In August 2021, Becton, Dickinson and Company launched its new and fully automated high-throughput diagnostic system, BD COR System. The system uses robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the US.
In July 2021, DiaSorin S.p.A. acquired the leading company of multiplex assays, Luminex Corporation, for a price of USD 37.00 per share, that corresponds to a total equity value of approximately USD 1.8 billion.
In February 2021, Thermo Fisher Scientific acquired Mesa Biotech, a privately-held point-of-care molecular diagnostic company. This acquisition strengthened Thermo Fisher's operational excellence, access to raw materials, and existing distribution & sales channels with Mesa's innovative platform with a diverse array of diagnostic products, such as Accula System by Mesa Biotech that is dedicated to COVID-19 testing.
Multiplex Assays Market - Report Highlights:
More Refined Presentation of the Competitive Landscape and Recent Market Developments:
We have added market shares for top players. Recent developments are helpful to know the market trends and growth strategies adopted by players in the market. The report provides updated developments in product launches, collaboration, acquisitions, and partnerships.
Additional Information: The current edition of the report covers recession impact analysis.
More Refined Presentation of the Company Profiles Segment: Company profiles give a glimpse of the key players in the market with respect to business overviews, financials, product offerings, and recent developments. The new edition of the report provides an updated product portfolio of the companies profiled in the report. A total of 25 companies have been profiled. These companies have emerged as key market players in recent years due to the products they offer, and various strategic investments undertaken in the multiplex assays market space.
Newer and Improved Representation of Financial Information: The new edition of the report provides updated financial information in the context of the multiplex assays market until 2021/2022 (depending on availability) for each listed company. This will help analyze the present status of the profiled companies in terms of their financial strength, profitability, key revenue-generating country/region, business segment focus in terms of the highest revenue-generating segments, and investments in research and development activities.
Recent Market Developments: Recent developments are important to understand the market trends and growth strategies adopted by players operating in the global multiplex assays market. The current edition of this report provides updated developments of profiled players from January 2020 to April 2023, indicating a continuation of the previous version. Product launches and acquisitions are the principal growth strategies adopted by market players in this period.
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/multiplex-assays-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/multiplex-assays.asp
Future Outlook and Growth Potential of the Veterinary API Market
The global Veterinary API Market is estimated to grow significantly. By 2028, it is projected to reach a value of USD 11.9 billion, showing a compound annual growth rate (CAGR) of 6.9% during the forecast period, starting from USD 8.5 billion in 2023 according to a new report by MarketsandMarkets™. The expansion of the Veterinary API Market is driven by various factors, including rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91801752
The Veterinary API Market is divided into three types based on synthesis types such as Chemical based API, Biological API, and Highly potent API. The Chemical based API segment accounted for the highest share of the global Veterinary API Market in 2022. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period. Growing demand for veterinary medicines, occurrence of new or emerging infectious diseases, and increasing research and development activities are some of the factors that are anticipated to promote market expansion throughout the projected period.
The Veterinary API Market, based on Animal Type is divided into two types such as companion animals and livestock animals. In 2022, companion animals held the highest market share for Veterinary API Market. Growing emphasis on preventive healthcare for companion animals and Increasing pet ownership are some of the factors that contribute to the big proportion of this market.
In the forecast period, Asia Pacific in the Veterinary API Market will have the fastest rising regional growth. Large number of veterinary hospitals and healthcare facilities, increasing spread of diseases in animals, and rising manufacturing infrasturcture for veterinary API manufacturing are the main factors driving market growth. Asia Pacific region has experienced an increase in pet ownership, coupled with a rising awareness of animal health and welfare. This has led to a higher demand for veterinary medicines and APIs in the region. Many countries in the Asia Pacific region, such as China, India, and South Korea, have seen substantial economic growth and increased disposable income. This has resulted in a greater ability and willingness to invest in the healthcare of companion animals, driving the expansion of veterinary API manufacturing infrastructure.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91801752
Following is a list of the major players (supply-side) in the Veterinary API Market that this study refers to:
· By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20%
· By Designation: C-level- 35%, Director Level—25%, and Others- 40%
· By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2%
Research Coverage:
The market study analyzes the main market segments for Veterinary APIs. The objective of this study is to estimate the market's size and growth potential across several categories according to API Type, Synthesis Type, Route of Administration, and Animal Type. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.
Key Benefits of Buying the Report:
The study provides data regarding the Veterinary API Market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.
The report provides insights on the following pointers:
Analysis of key drivers (Rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures), restraints (High costs of veterinary diagnostic and treatment) opportunities (Rising awareness about animal health and welfare and Untapped emerging economies), and challenges (Challenges In Large Molecule APIs Synthesis) influencing the growth of the Veterinary API Market.
Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for Veterinary API Market
Market Development:
Comprehensive data on attractive markets, and the research analyzes the global Veterinary API Market
Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the Veterinary API Market.
Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the Veterinary API Market like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India)
The prominent players in the global Veterinary API Market are
· Phibro Animal Health Corporation (US)
· Fabbrica Italiana Sintetici S.p.A. (Italy)
· Sequent Scientific Ltd. (India)
· Excel Industries Ltd. (India)
· NGL Fine-Chem Ltd. (India)
· Insulnsud Pharma (Spain)
· Menadiona Sl (Spain)
· Rochem International Inc. (US)
· and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)
Recent Developments:
· In 2021, Sequent Scientific Ltd. (India) received WHO–GENEVA approval for API Praziquantel (Anthelmintic) under the prequalification program.
· In 2020, Sequent Scientific Ltd. Opened a state-of-the-art animal health R&D center in Mumbai, India.
Future Outlook and Growth Potential of the Adhesion Barrier Market
Adhesion Barrier Market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 7.4%.
The main drivers promoting the development of this market are the rising number of surgeries and sports-related injuries, an increasing elderly population, and the rising awareness of adhesion formation and diseases associated with adhesions.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China)and Allosource (US).
Based on products, the adhesion barriers market is further segmented into synthetic and natural adhesion barriers. Synthetic adhesion barriers are further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol, and other synthetic adhesion barriers. the hyaluronic acid based adhesion barriers segment accounted for the largest share of the synthetic adhesion barrier market, owing to their properties of biocompatibility and bioresorbable.
In 2022, based on applications, General/Abdominal Surgeries held the largest share of the adhesion barriers market. The large share of this segment can be attributed to factors such as the higher risk of post-surgical adhesion formation in General/Abdominal Surgeries, the growing volume of General/Abdominal Surgeries, and the availability of several commercialized adhesion barrier products for General/Abdominal Surgeries.
On the basis of region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Adhesion barrier market is expected to grow in the APAC due to factors such as steadily increasing geriatric population, the epidemiological shift from infectious to chronic diseases, and rising medical tourism. As a result, the APAC is anticipated to grow faster than other regions during the forecast period with the highest CAGR.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
A breakdown of the primary participants (supply-side) for the adhesion barrier market referred to for this report is provided below:
By Company Type: Tier 1: 42%, Tier 2: 35%, and Tier 3: 23%
By Designation: C-level Executives: 28%, Directors: 35%, and Others: 37%
By Region: North America: 33%, Europe: 24%, Asia Pacific: 18%, Latin America: 10%; Middle East: 10%; Africa: 5%
Research Coverage:
The market study covers the adhesion barrier market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by formulation, by application, by end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall adhesion barrier market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (Rising geriatric population, increase in the volume of surgeries and sports-related injuries, increasing awareness about the medical implications of adhesions), restraints (Reluctance of surgeons to use adhesion barriers, Product recalls), opportunities (Untapped emerging markets) and challenges (Stringent regulations resulting in limited technological innovations) influencing the growth of the adhesion barrier market
Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by type of product, formulation, application, and region.
Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global adhesion barrier market.
Market Development: Comprehensive information on the lucrative emerging markets by type of product , formulation, application, and region.
Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global adhesion barrier market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global adhesion barrier market.
Recent Developments:
In February 2020, Baxter’s acquired the Seprafilm Adhesion Barrier and related assets from Sanofi to strengthen its hemostate and sealant portfolio and company’s presence in this market.
In January 2021, Integra Lifesciences Holdings Corporation acquired Acell Inc. This acquisition enables integra to provide more comprehensive complex wound management solutions.